Advances in Genomics and Proteomics in the $8.62 Billion Molecular Diagnostics Market

LONDON, April 23, 2020 /PRNewswire/ -- The advances in genomics and proteomics is a key trend driving the growth of the molecular diagnostics market. Polymerase chain reaction (PCR) is a recent development in genomics and helps in discovering new approaches to molecular diagnosis for disease diagnosis and pathogenesis of diseases. This enables better monitoring and a fast diagnosis, and major organizations are investing to have a competitive edge. Following the trend, Genome Canada, a source of funding for genomics and proteomics, announced plans to invest $16 million between the period April 2015 and March 2017. The growing research in proteomics and genomics will help develop more advanced molecular diagnostic techniques in the forecast period.

Read More On The Business Research Company's Molecular Diagnostics Market Report:

Molecular Diagnostics Market Overview And Segments

Molecular diagnostics is a term used to describe a class of techniques that are used to examine biological markers in the genetic code (genome) of an organism and to determine how their cells express their genes as proteins. The molecular diagnostics market covered in this report is segmented by technology into polymerase chain reaction (PCR), DNA sequencing, and next-generation sequencing. It is also segmented by product into instruments, reagents and consumables, and software & services. By application it is segmented into oncology, pharmacogenomics, infectious diseases, genetic testing, neurological disease, cardiovascular disease, microbiology, and others, and by end-user the market is segmented into hospitals, laboratories, and others (blood banks, home health agencies, and nursing homes).

The Molecular Diagnostics Market Will Reach $12.09 Billion By 2023

The global molecular diagnostics market was worth $8.62 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 8.82% and reach $12.09 billion by 2023. The global prevalence of infectious diseases and cancers of different forms drives the molecular diagnostics market. The increasing prevalence of infectious diseases and various types of cancer creates a demand for new diagnostic procedures including fast and specific molecular diagnostic tests. According to the International Agency for Research on Cancer (IARC), in 2018, there were 17.0 million new cancer cases and 9.5 million cancer deaths worldwide, and by 2040, the number is expected to increase to 27.5 million new cancer cases and 16.3 million cancer deaths. The increasing prevalence of cancer globally will increase the demand for molecular diagnostic tests for effective diagnosis of cancer over the coming years, thereby contributing to the growth of the market.

Request A Free Sample Of The Molecular Diagnostics Market Report:

Bruker Corporation Acquires Hain Lifescience GmbH

Companies in the molecular diagnostics market invest in mergers and acquisitions to strengthen their businesses. In August 2018, Bruker Corporation, an American based manufacturer of scientific instruments for molecular and materials research announced plans to acquire majority stake in Hain Lifescience GmbH for an undisclosed amount. This acquisition will help Bruker to expand its presence in attractive microbiology and virology infectious disease MDx markets, add tuberculosis and mycobacteria testing, virology, and human genetics MDx, and add a pipeline for multiplex syndromic panel testing to its portfolio. Hain Lifescience GmbH is an infectious disease molecular diagnostics (MDx) specialist and provides solutions for detecting microbial and viral pathogens, antibiotic resistance testing, and human genetic diseases.

Major players in the global molecular diagnostics market include Becton, BioMérieux SA., Danaher Corporation, Grifols, Hologic Inc., Novartis AG, QIAGEN, Siemens Healthcare GmbH, Abbott, Dickinson and Company, Hoffmann-La Roche Ltd., BD, Bio-Rad Laboratories, Johnson & Johnson, Cepheid, Roche Diagnostics, Alere, Bayer AG, Dako, Sysmex Corporation, Agilent Technologies, Diasorin, Illumina, Thermo Fisher Scientific, and Biocartis Group NV.

Here Is A List Of Similar Reports By The Business Research Company:

Sequencing Market By Type (Next Generation Sequencing, Third Generation Sequencing And Sanger Sequencing), By Products (Consumables, Software, Sequencing Services And Instruments), By Regions And By Trends - Global Forecast To 2023

Polymerase Chain Reaction (PCR) And Real-Time Polymerase Chain Reaction (PCR) Testing Global Market Report 2020-30: Covid 19 Implications And Growth

Genomics Market Global Report 2020: Covid 19 Implications And Growth

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Contact Information

The Business Research Company
Europe: +44-207-1930-708
Asia: +91-8897263534
Americas: +1-315-623-0293
Follow us on LinkedIn:
Follow us on Twitter:

View original content:

SOURCE The Business Research Company